Search Results - "Cleeland, C S"

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients by Maringwa, J., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Reeve, B.B., Gotay, C., Greimel, E., Flechtner, H., Cleeland, C.S., Schmucker-Von Koch, J., Weis, J., Van Den Bent, M.J., Stupp, R., Taphoorn, M.J., Bottomley, A.

“…We aimed to determine the smallest changes in health-related quality of life (HRQoL) scores in the European Organisation for Research and Treatment of Cancer…”
Get full text

Symptom burden in patients undergoing autologous stem-cell transplantation by ANDERSON, K. O, GIRALT, S. A, MENDOZA, T. R, BROWN, J. O, NEUMANN, J. L, MOBLEY, G. M, WANG, X. S, CLEELAND, C. S

“…Patients who undergo autologous peripheral blood stem cell (PBSC) transplantation experience multiple symptoms that adversely affect quality of life. We…”
Get full text

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing by GABRILOVE, Janice L, CLEELAND, Charles S, LIVINGSTON, Robert B, SAROKHAN, Brenda, WINER, Eric, EINHORN, Lawrence H

“…To prospectively evaluate the effectiveness, safety, and clinical benefits of once-weekly epoetin alfa therapy as an adjunct to chemotherapy in anemic cancer…”
Get full text

The rapid assessment of Fatigue severity in cancer patients: Use of the Brief Fatigue Inventory by MENDOZA, T. R, WANG, X. S, CLEELAND, C. S, MORRISSEY, M, JOHNSON, B. A, WENDT, J. K, HUBER, S. L

“…Fatigue is a major disease and treatment burden for cancer patients. Several scales have been created to measure fatigue, but many are long and difficult for…”
Get full text

Validation of the German Version of the Brief Pain Inventory by Radbruch, Lukas, Loick, Georg, Kiencke, Peter, Lindena, Gabriele, Sabatowski, Rainer, Grond, Stephan, Lehmann, Klaus A., Cleeland, Charles S.

“…The Brief Pain Inventory is a comprehensive instrument for pain assessment and has been validated in several languages. A validated German version was not…”
Get full text

Pain and treatment of pain in minority patients with cancer : The Eastern Cooperative Oncology Group minority outpatient pain study by CLEELAND, C. S, GONIN, P. R, BAEZ, L, LOEHRER, P, PANDYA, K. J

“…Clinics that primarily see members of ethnic minority groups have been found to provide inadequate treatment of cancer-related pain. The extent of…”
Get full text

Pain and Its Treatment in Outpatients with Metastatic Cancer by Cleeland, Charles S, Gonin, Rene, Hatfield, Alan K, Edmonson, John H, Blum, Ronald H, Stewart, James A, Pandya, Kishan J

“…Pain is the most persistent and incapacitating symptom of recurrent or metastatic cancer. A large proportion of patients with metastatic cancer have pain long…”
Get full text

Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group by Cleeland, C. S., Portenoy, R. K., Rue, M., Mendoza, T. R., Weller, E., Payne, R., Kirshner, J., Atkins, J. N., Johnson, P. A., Marcus, A.

“…Background:: Cancer pain is highly prevalent and commonly undertreated. This study was designed to determine whether dissemination of a clinical protocol for…”
Get full text

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) by Basch, Ethan, Reeve, Bryce B, Mitchell, Sandra A, Clauser, Steven B, Minasian, Lori M, Dueck, Amylou C, Mendoza, Tito R, Hay, Jennifer, Atkinson, Thomas M, Abernethy, Amy P, Bruner, Deborah W, Cleeland, Charles S, Sloan, Jeff A, Chilukuri, Ram, Baumgartner, Paul, Denicoff, Andrea, St Germain, Diane, O'Mara, Ann M, Chen, Alice, Kelaghan, Joseph, Bennett, Antonia V, Sit, Laura, Rogak, Lauren, Barz, Allison, Paul, Diane B, Schrag, Deborah

“…The standard approach for documenting symptomatic adverse events (AEs) in cancer clinical trials involves investigator reporting using the National Cancer…”
Get full text

Minority cancer patients and their providers : Pain management attitudes and practice by ANDERSON, K. O, MENDOZA, T. R, CLEELAND, C. S, VALERO, V, RICHMAN, S. P, RUSSELL, C, HURLEY, J, DELEON, C, WASHINGTON, P, PALOS, G, PAYNE, R

“…The goals of the current studies were: 1) to determine the pain treatment needs of socioeconomically disadvantaged African-American and Hispanic patients with…”
Get full text

Pain assessment: global use of the Brief Pain Inventory by Cleeland, C S, Ryan, K M

“…Poorly controlled cancer pain is a significant public health problem throughout the world. There are many barriers that lead to undertreatment of cancer pain…”
Get more information

Physician attitudes and practice in cancer pain management : a survey from the Eastern Cooperative Oncology Group by VON ROENN, J. H, CLEELAND, C. S, GONIN, R, HATFIELD, A. K, PANDYA, K. J

“…The Eastern Cooperative Oncology Group (ECOG) conducted a groupwide survey to determine the amount of knowledge about cancer pain and its treatment among…”
Get full text

Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling by Cleeland, C S, Nakamura, Y, Mendoza, T R, Edwards, K R, Douglas, J, Serlin, R C

“…We investigated the question of how cultural and linguistic backgrounds affect relationships among ratings (reported by patients with metastatic cancer) of…”
Get more information

Pain assessment: the advantages of using pain scales in lysosomal storage diseases by Cleeland, CS

“…Routine and standardized assessment of pain should be conducted in patients with conditions, such as Fabry disease, that are associated with chronic pain. Such…”
Get full text

A Brief Cancer Pain Assessment Tool in Japanese: The Utility of the Japanese Brief Pain Inventory—BPI-J by Uki, Jiro, Mendoza, Tito, Cleeland, Charles S., Nakamura, Yoshio, Takeda, Fumikazu

“…Despite recognition that pain management is an important component in the treatment of Japanese cancer patients, progress in this area has been slowed by the…”
Get full text

The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain by Wang, X S, Mendoza, T R, Gao, S Z, Cleeland, C S

“…We describe the development of a Chinese version of the Brief Pain Inventory (BPI-C) and demonstrate its reliability and validity. We also report the use of…”
Get more information

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function by Serlin, Ronald C, Mendoza, Tito R, Nakamura, Yoshio, Edwards, Katherine R, Cleeland, Charles S

“…As a way of delineating different levels of cancer pain severity, we explored the relationship between numerical ratings of pain severity and ratings of pain's…”
Get more information

Validation of the Brief Pain Inventory in a Taiwanese Population by Ger, Luo-Ping, Ho, Shung-Tai, Sun, Wei-Zen, Wang, Ming-Shang, Cleeland, Charles S

“…Assessment of pain in cancer patients is very important to all health care professionals. This paper describes the development of a Taiwanese version of the…”
Get full text

The Assessment of Cancer Pain in North India: The Validation of the Hindi Brief Pain Inventory—BPI-H by Saxena, Abha, Mendoza, Tito, Cleeland, Charles S.

“…The status of pain treatment for cancer patients in India is largely undocumented. Although many languages and dialects are spoken throughout the country,…”
Get full text

Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid by Vadhan-Raj, S., von Moos, R., Fallowfield, L.J., Patrick, D.L., Goldwasser, F., Cleeland, C.S., Henry, D.H., Novello, S., Hungria, V., Qian, Y., Feng, A., Yeh, H., Chung, K.

“…Patients with metastatic bone disease are living longer in the metastatic stage due to improvements in cancer therapy, making strategies to prevent the…”
Get full text